Atlas Trials

68Ga-PSMA-R2 in Patients With Biochemical Relapse (BR) and Metastatic Prostate Cancer (mPCa)

Clinical trial NCT03490032 · COMPLETED

Trial details

NCT number
NCT03490032
Sponsor
Advanced Accelerator Applications
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Prostate Cancer Metastatic
Start date
2018-05-23
Primary completion
2019-08-20
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.